Collagen, antioxidants, and nutrients that support skin health, elasticity, and a radiant complexion.
12 itemsVitamin C’s role as a collagen cofactor goes far beyond colds. Explore evidence on skin, joints, wound healing, and traditional sources like amla and acerola.
Vitamin C’s underrated role as a collagen cofactor—what science says about skin aging, wound healing, and tendon support, plus insights from traditional vitamin C–rich foods.
Vitamin C’s role in collagen synthesis—how it may support skin elasticity, tendon integrity, and wound healing, plus traditional sources like amla, acerola, and camu camu.
Vitamin C’s most vital job may be powering collagen synthesis. Learn how it supports skin, gums, tendons, and wound repair—what’s proven, what’s promising, and how traditional sources like amla fit in.
A focused, evidence-based look at vitamin C’s essential role as a collagen cofactor, what clinical studies show for skin, wound healing, and connective tissue, and how traditional vitamin C–rich fruits fit in.
Vitamin C’s role in collagen synthesis—what research suggests for skin, wound repair, and joint health, plus delivery formats and traditional sources.
Vitamin C’s lesser-known job: cofactor for collagen-building enzymes. Learn how this shapes skin health, joints, and wound healing, what the evidence says, and how traditional sources like amla and acerola fit in.
Vitamin C is essential for collagen synthesis. Research suggests adequate vitamin C may support skin appearance, tendon remodeling, and wound repair—especially when combined with good iron status and appropriate loading—while traditional sources like amla, acerola, and camu camu add complementary phytochemicals.
Vitamin C’s unsung role as a collagen cofactor: what research suggests for skin integrity, wound healing, and connective tissue—plus insights on amla, acerola, and camu camu.
Type I, II, III — not all collagen is the same. Which forms actually work, optimal dosing, and how to pair collagen with vitamin C for absorption.
Eczema (atopic dermatitis, AD) and psoriasis are chronic inflammatory skin diseases that share some management principles (moisturization, anti‑inflammatory therapy, and trigger control) but differ in immune pathways, clinical appearance, and many treatment choices. In Western medicine, diagnosis is clinical: AD often begins in childhood, with pruritic, eczematous patches in flexural areas and a relapsing course, accompanied by xerosis and personal or family atopy. Validated criteria include Hanifin–Rajka and the UK Working Party. Psoriasis typically presents with well‑demarcated erythematous plaques with silvery scale on extensor surfaces, scalp, and sometimes nails or joints; severity and response are tracked with tools like PASI and DLQI. Standard care emphasizes barrier repair (emollients), topical anti‑inflammatories (a potency ladder of corticosteroids; non‑steroidal options like calcineurin inhibitors or PDE‑4 inhibitors), phototherapy (narrowband UVB), and systemic/biologic agents as severity escalates. For AD, newer small‑molecule JAK inhibitors have expanded options for moderate‑to‑severe disease. For psoriasis, highly targeted biologics against IL‑17 or IL‑23 pathways have transformed outcomes for many patients. These approaches are guideline‑driven and supported by strong evidence, but they are not curative, responses vary, and long‑term safety, cost, and access are practical constraints. Eastern and traditional modalities frame these conditions differently. In Traditional Chinese Medicine (TCM), eczema and psoriasis reflect internal imbalances such as “blood heat,” “blood dryness,” or “damp‑heat,” inferred from the lesion character (weeping vs dry), color, and systemic patterns. Therapy aims to clear heat, resolve dampness, nourish blood, and calm wind, often combining individualized herbal formulas with acupuncture and dietary guidance. Several randomized trials—including classic UK studies of standardized CHM formulas for atopic eczema—suggest short‑
Eczema (atopic dermatitis, AD) and asthma frequently coexist as part of the atopic spectrum. Epidemiologic studies show that people with AD have a higher risk of developing asthma, especially when ...
